替罗非班治疗急性非ST段抬高心肌梗死临床分析

Clinical Analysis on the Treatment of Acute Class were Not St-Elevation Myocardial Infarction

目的探讨替罗非班治疗急性非ST段抬高的心肌梗死的临床疗效和安全性,为制定完善的治疗方案提供数据支持。方法回顾性分析2009年6月至2011年6月我院采用替罗非班治疗的112例非ST段抬高的急性心肌梗死患者的临床资料,并以同期采用常规治疗的112例患者为对照组,比较2组患者的治疗效果和不良反应发生率。结果观察组80.36%的患者梗死相关血管血流分级达到Ⅲ级,明显高于对照组,组间比较差异具有统计学意义(P<0.05),2组患者并发症发生率比较差异无统计学意义(P>0.05)。结论替罗非班治疗急性非ST段抬高的心肌梗死疗效确切,值得临床推广。

Objective To study the treatment of acute class for had not st--segment elevation myocardial infarction of the clinical efficacy and safety,to make the perfect treatment plan to provide data to support.Methods Retrospective analysis from June 2009 to June 2011 by had treatment for our class of 112 cases of st--segment elevation acute myocardial infarction patients for clinical material,and the same period with the conventional treatment of 112 patients in the control group,compared between the two groups for the treatment of patients effect and adverse reaction rate.Results The observation group 80.36% of patients with vascular infarction related to blood flow Ⅲ level,classification were higher than that of control group,comparative differences between groups are statistically significant （P〈0.05）,two groups of patients complication rate of comparative differences was statistically significant（P〉0.05）.Conclusion For the treatment of acute class were not st--segment elevation myocardial infarction of the definite effect,and clinical promotion.